Further, PEITC and SFN treatment in human prostate cancer PC-3 cells inhibits both phosphorylation of IKK/IκB and nuclear translocation of NF-κB p65 subunit, which suppresses the NF-κB signaling pathway [177]. The gene discussed is NFKB1; the disease is prostate cancer.